Cisplatin plus vindesine versus cisplatin plus VP16 versus doxorubicin plus cytoxan in non-small-cell carcinoma of the lung. A randomized study

Tumori

Volumn 72, Issue 4, 1986, Pages 417-425

  Paccagnella, A ^a   Brandes, A ^a   Pappagallo, G L ^a   Simioni, G ^b   Fosser, V P ^b   Vinante, O ^b   Salvagno, L ^b   De Besi, P ^b   Chiarion Sileni, V ^b   Fornasiero, A ^b  

^a Div di Oncologia Medica Direzione   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; VINDESINE;

ADVERSE DRUG REACTION; ALOPECIA; AUDITORY SYSTEM; BLOOD AND HEMOPOIETIC SYSTEM; BONE MARROW DEPRESSION; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CLINICAL TRIAL; CONTROLLED STUDY; DIGESTIVE SYSTEM; DRUG COMPARISON; DRUG EFFICACY; DRUG THERAPY; GASTROINTESTINAL SYMPTOM; GASTROINTESTINAL TOXICITY; HEARING IMPAIRMENT; HUMAN; INTOXICATION; INTRAVENOUS DRUG ADMINISTRATION; LUNG CARCINOMA; MAJOR CLINICAL STUDY; NERVOUS SYSTEM; NEUROTOXICITY; OTOTOXICITY; PERIPHERAL NEUROPATHY; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY SYSTEM; SKIN TOXICITY; THERAPY;

EID: 0022971847     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089168607200414     Document Type: Article

References (0)